What is the Welcure Drugs & Pharmaceuticals Ltd share price today?

The share price of BSE:WELCURE-X on 07 Sep 2026 (as of 11:02:54 IST) is ₹0.24.

What is the BSE:WELCURE-X 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the BSE:WELCURE-X 52 week high low range shows a high of ₹0.96 and a low of ₹0.19.

What is the Welcure Drugs & Pharmaceuticals Ltd market cap?

As on 07 Sep 2026, Welcure Drugs & Pharmaceuticals Ltd market cap is ₹28.43 Cr.

What is the shareholding pattern of Welcure Drugs & Pharmaceuticals Ltd Stock?

The shareholding pattern of Welcure Drugs & Pharmaceuticals Ltd, as of last reported-on 31 Mar 2026 is: Promoters: 0% Foreign Institutional Investors (FII): 0% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 100% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Welcure Drugs & Pharmaceuticals Ltd?

The Price-to-Earnings (PE) ratio of Welcure Drugs & Pharmaceuticals Ltd is 0, and the Price-to-Book (PB) ratio is 1.00, as on 07 Sep 2026.

Welcure Drugs & Pharmaceuticals Share Price

0.21-0.01 (-4.55%)

-65.52% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-4.55%

1 Week

+0.00%

1 Month

+0.00%

3 Month

-19.23%

6 Month

-16.00%

YTD

-50.00%

1 Year

-65.52%

5 Year

-73.72%

10 Year

Max

+437.21%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

0.20

0.19

High

0.23

0.24

0.25

0.28

0.36

0.81

About

Welcure Drugs & Pharmaceuticals Ltd is engaged in the business of manufacture and marketing of pharmaceuticals formulations in the form of tablets capsules and dry syrups. The Company is manufacturing Read more

Trading

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

ADANIENT-ANSE

AEGISLOG-ANSE

CPPLUS-ANSE

PREMIERENE-ANSE

REDINGTON-ANSE

HONASA-ANSE

LLOYDSENT-ANSE

CELLO-ANSE

JSLL-ANSE

SREEL-TNSE

WELCURE-XNSE

LTP

1W Low

1W High

Market cap (₹)

2920-79.1 (-2.64%)

2900

3025

4,04,763Cr

1373.5-43.75 (-3.09%)

1347.50

1528

49,337Cr

3798.85+447 (13.34%)

3344.30

3875.70

45,264Cr

898-5 (-0.55%)

885.10

919.30

41,326Cr

406.45+6.75 (1.69%)

390.60

419.55

31,353Cr

475.35-4.25 (-0.89%)

466

491.75

15,804Cr

75.52+6.73 (9.78%)

67.25

77.10

11,326Cr

340.15+17.6 (5.46%)

314.90

344.10

7,311Cr

511.55+1.9 (0.37%)

505

530.50

6,517Cr

299.95+13.15 (4.59%)

266.60

305

673Cr

0.21+0 (0.00%)

0.20

0.24

27Cr

Welcure Drugs & Pharmaceuticals Share Price

0.21-0.01 (-4.55%)

-65.52% past 1 Year

Financial overview

Compounded Sales Growth

10 years86%

5 years212%

3 years516%

Last year0%

Compounded Profit Growth

10 years81%

5 years-

3 years351%

Last year1341%

Stock Price CAGR

10 years-

5 years-23%

3 years-16%

1 year-66%

Return on Equity

10 years18%

5 years33%

3 years2%

Last year4%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
86%	212%	516%	0%
81%	-	351%	1341%
-	-23%	-16%	-66%
18%	33%	2%	4%

Peer Comparison

Symbol

ADANIENT-A

AEGISLOG-A

CPPLUS-A

PREMIERENE-A

REDINGTON-A

HONASA-A

LLOYDSENT-A

CELLO-A

JSLL-A

SREEL-T

WELCURE-X

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
2,920	₹404763 Cr	54.37	-8.91	105.06	₹9339 Cr
1,373.5	₹49337 Cr	39.43	13.8	41.65	₹898 Cr
3,798.85	₹45264 Cr	94.84	12.07	45.29	₹368 Cr
898	₹41326 Cr	24.82	10.2	45.28	₹1510 Cr
406.45	₹31353 Cr	18.43	6.22	24.36	₹1490 Cr
475.35	₹15804 Cr	63.5	2.77	8.99	₹200 Cr
75.52	₹11326 Cr	100.86	0.38	0.91	₹283 Cr
340.15	₹7311 Cr	23.37	3.32	17.46	₹332 Cr
511.55	₹6517 Cr	27.56	5.31	23.32	₹222 Cr
299.95	₹673 Cr	20.51	3.02	14.74	₹29 Cr
0.21	₹27 Cr	—	-0.4	-0.04	-₹5 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Unsecured Loans

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹112 Cr	₹13 Cr	₹13 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr
-₹10 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹13 Cr	-₹12 Cr	-₹5 Cr
-₹10 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹12 Cr	-₹13 Cr	-₹12 Cr	-₹5 Cr
₹103 Cr	₹1 Cr	₹2 Cr	₹9 L	₹7 L	₹1 L	₹2 L	₹2 L	₹4 L	₹1 L	-₹7 L	-₹8 L	-₹8 L	-₹10 L	₹71,414	-₹1 Cr	₹42 L	₹7 Cr
₹123 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹3 Cr	₹3 Cr	₹3 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹51 L	₹51 L	₹0
₹123 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹3 Cr	₹4 Cr	₹3 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹3 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹4 Cr	₹4 Cr	₹6 Cr
₹38 Cr	₹2 L	₹1 L	₹38,150	₹35,916	₹1 L	₹61,162	₹36,000	₹36,174	₹39,585	₹13 L	₹13 L	₹13 L	₹13 L	₹4 L	₹97 L	₹85 L	₹2 Cr
₹62 L	₹93,000	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹34 L	₹0	₹79,189	₹0
₹41 Cr	₹3 L	₹1 L	₹38,150	₹35,916	₹1 L	₹61,162	₹36,000	₹36,174	₹39,585	₹13 L	₹13 L	₹13 L	₹13 L	₹38 L	₹5 Cr	₹5 Cr	₹8 Cr
₹267 Cr	₹1 Cr	₹2 Cr	₹10 L	₹7 L	₹2 L	₹3 L	₹2 L	₹4 L	₹2 L	₹6 L	₹5 L	₹5 L	₹4 L	₹38 L	₹7 Cr	₹9 Cr	₹18 Cr
₹0	₹0	₹33 L	₹33 L	₹33 L	₹33 L	₹33 L	₹33 L	₹27 L	₹27 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹15,000
₹123 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹3 Cr	₹4 Cr	₹3 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹8 L	₹6 L	₹6 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹8 Cr	₹9 Cr	₹9 Cr
₹5 L	₹4 L	₹30,000	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹4 Cr	₹3 Cr	₹3 Cr
₹3 L	₹2 L	₹6 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹4 Cr	₹5 Cr	₹6 Cr
₹0	₹0	₹17 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹16 L	₹16 L	₹44 L
₹0	₹0	₹17 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹16 L	₹16 L	₹44 L
₹85 Cr	₹1 Cr	₹1 Cr	₹3 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹85 Cr	₹1 Cr	₹2 Cr	₹3 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹5 Cr	₹6 Cr	₹6 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹144 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹29 L	₹72 L
₹19 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹12 L	₹1 Cr	₹2 Cr	₹9 Cr
₹13 L	₹2 L	₹10,000	₹7 L	₹5 L	₹53,000	₹1 L	₹1 L	₹2 L	₹52,908	₹5 L	₹5 L	₹5 L	₹4 L	₹26 L	₹18 L	₹24 L	₹9 L
₹2 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹5 L	₹0
₹20 Cr	₹1 L	₹50,000	₹0	₹3 L	₹2 L	₹1 L	₹1 L	₹2 L	₹1 L	₹52,685	₹71,405	₹38,256	₹5,786	₹0	₹1 Cr	₹1 Cr	₹2 Cr
₹182 Cr	₹3 L	₹60,000	₹7 L	₹7 L	₹2 L	₹3 L	₹2 L	₹4 L	₹2 L	₹6 L	₹5 L	₹5 L	₹4 L	₹38 L	₹2 Cr	₹3 Cr	₹11 Cr
₹141 Cr	₹14,000	-₹80,000	₹6 L	₹7 L	₹1 L	₹2 L	₹2 L	₹4 L	₹1 L	-₹7 L	-₹8 L	-₹8 L	-₹10 L	₹71,414	-₹3 Cr	-₹2 Cr	₹4 Cr
₹267 Cr	₹1 Cr	₹2 Cr	₹10 L	₹7 L	₹2 L	₹3 L	₹2 L	₹4 L	₹2 L	₹6 L	₹5 L	₹5 L	₹4 L	₹38 L	₹7 Cr	₹9 Cr	₹18 Cr
₹9	₹1	₹1	₹0	₹0	₹0	₹0	₹0	₹0	₹0	-₹0	-₹0	-₹0	-₹0	₹0	-₹1	₹0	₹6
₹1	₹0	₹1	₹0	₹0	₹0	₹0	₹0	₹0	₹0	-₹0	-₹0	-₹0	-₹0	₹0	-₹1	₹0	₹6

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008
₹3 Cr	-₹17 L	₹10 L	₹2 L	₹6 L	-₹94,000	₹38,781	-₹2 L	₹3 L	₹9 L	₹58,683	₹29,439	₹1 L	-₹10 L	₹1 Cr	-₹2 Cr	-₹7 Cr	-₹2 Cr
₹76,000	₹4 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	-₹28,230	-₹20,074	-₹12,534	-₹31,949	-₹22 L	-₹1 Cr	₹2 Cr	₹5 Cr	₹2 Cr
-₹225 Cr	₹1 L	₹50,000	-₹50,266	-₹1 L	-₹3,000	-₹16,441	₹85,000	-₹93,005	-₹13 L	₹23,720	-₹35,649	-₹34,970	₹9 L	-₹3 Cr	₹1 Cr	₹2 Cr	₹2 Cr
-₹222 Cr	-₹13 L	₹11 L	₹2 L	₹4 L	-₹97,000	₹22,340	-₹1 L	₹2 L	-₹5 L	₹62,329	-₹18,744	₹61,265	-₹23 L	-₹3 Cr	₹98 L	₹68 L	₹1 Cr
-₹222 Cr	-₹13 L	₹11 L	₹2 L	₹4 L	-₹97,000	₹22,340	-₹1 L	₹2 L	-₹5 L	₹62,329	-₹18,744	₹61,265	-₹23 L	-₹3 Cr	₹97 L	₹65 L	₹1 Cr
-₹6 L	₹17 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹3 L	-₹9,483	-₹2 L	₹3 L	₹19 L	₹6 Cr	₹19 L	-₹3 L	-₹2 L
₹222 Cr	-₹2 L	-₹17 L	₹0	₹0	₹0	₹0	₹0	₹0	₹450	₹0	₹1,000	₹0	₹0	-₹3 Cr	-₹1 Cr	-₹47 L	-₹1 Cr
₹11 L	₹2 L	-₹7 L	₹2 L	₹4 L	-₹97,000	₹22,340	-₹1 L	₹2 L	-₹2 L	₹52,846	-₹3 L	₹4 L	-₹4 L	₹2 L	-₹6 L	₹15 L	-₹1 L
₹2 L	₹12,000	₹7 L	₹5 L	₹52,715	₹2 L	₹1 L	₹2 L	₹52,908	₹3 L	₹2 L	₹5 L	₹1 L	₹5 L	₹4 L	₹24 L	₹9 L	₹10 L
₹13 L	₹2 L	₹10,000	₹7 L	₹5 L	₹53,000	₹1 L	₹1 L	₹2 L	₹52,908	₹3 L	₹2 L	₹5 L	₹1 L	₹5 L	₹18 L	₹24 L	₹9 L

Fundamental Ratios

Consolidated

Standalone

Welcure Drugs & Pharmaceuticals Share Price

0.21-0.01 (-4.55%)

-65.52% past 1 Year

Shareholding summary

Promoters

FII

DII

Others

100%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
100.00%	100.00%	100.00%	100.00%	100.00%	100.00%

Bulk & block deals

Name

Kifs Enterprise

Share India Securities Limited

Satish Kumar Grandhi

Share India Securities Limited

Transglobal Securities Ltd.

Saroj Kumar Kundu

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
23 Apr 2026	Sell	21.63 L	₹0.31	69.77 L	Bulk	0.564473	BSE
15 Apr 2026	Purchase	37.98 L	₹0.35	1.09 Cr	Bulk	0.87809	BSE
15 Apr 2026	Sell	37.98 L	₹0.35	1.09 Cr	Bulk	0.87809	BSE
15 Apr 2026	Sell	28.19 L	₹0.34	82.90 L	Bulk	0.670745	BSE
19 Mar 2026	Purchase	14.81 L	₹0.25	59.26 L	Bulk	0.479455	BSE
19 Mar 2026	Sell	17.22 L	₹0.26	66.25 L	Bulk	0.53599	BSE
04 Mar 2026	Purchase	21.99 L	₹0.30	73.31 L	Bulk	0.593171	BSE
04 Mar 2026	Purchase	20.13 L	₹0.30	67.10 L	Bulk	0.542936	BSE
04 Mar 2026	Purchase	17.33 L	₹0.30	57.75 L	Bulk	0.467296	BSE
04 Mar 2026	Sell	23.54 L	₹0.29	81.17 L	Bulk	0.656766	BSE

Insider trading & SAST

Client name

Lata Jain

Madhudevi S Bucha

Welcure Pharmaceuticals Private Limited

Arushi Jain

Sanjeev Jain

Dharam Chand Jain

Sandeep Jain

Dharam Chand Jain

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
23 Sep 2022	Other	Disposal	7.18	—	0	—	9.71 L	15 Sep 2022	Market	—	SAST	29(2)	—
22 Sep 2022	Other	Acquisition	6.53	6.53	0	—	8.82 L	06 Sep 2022 - 07 Sep 2022	Market	8,82,302	SAST	29(1)	—
22 Sep 2022	Other	Acquisition	4.12	10.65	0	—	5.57 L	06 Sep 2022 - 07 Sep 2022	Market	14,39,298	SAST	29(2)	—
21 Sep 2022	Other	Disposal	2.22798	0	24 L	₹8.89	2.70 L	19 Sep 2022	Market Sale	0	Insider Trading	—	Equity Shares
21 Sep 2022	Immediate Relative	Disposal	0.084738	0	92.32 K	₹8.99	10.27 K	19 Sep 2022	Market Sale	0	Insider Trading	—	Equity Shares
21 Sep 2022	Immediate Relative	Disposal	1.775783	0	19.13 L	₹8.89	2.15 L	19 Sep 2022	Market Sale	0	Insider Trading	—	Equity Shares
21 Sep 2022	Promoter & Director	Disposal	0.330071	0.1	3.74 L	₹9.35	40 K	20 Sep 2022	Market Sale	14,200	Insider Trading	—	Equity Shares
20 Sep 2022	Other	Disposal	5.07	—	0	—	6.86 L	05 Sep 2022 - 07 Sep 2022	Market	—	SAST	29(2)	—
20 Sep 2022	Other	Disposal	3.7	5.07	0	—	5 L	02 Sep 2022	Market	6,85,500	SAST	29(2)	—
20 Sep 2022	Promoter	Disposal	4.44	2.62	0	—	6 L	01 Sep 2022	Market	3,54,200	SAST	29(2)	—

Welcure Drugs & Pharmaceuticals Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Welcure Drugs & Pharmaceuticals Share Price

Welcure Drugs & Pharmaceuticals Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Welcure Drugs & Pharmaceuticals Share Price

Welcure Drugs & Pharmaceuticals Share Price

Oscillators

Moving averages

Welcure Drugs & Pharmaceuticals Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Welcure Drugs & Pharmaceuticals Share Price

Corporate Actions

Company details

Welcure Drugs & Pharmaceuticals Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Welcure Drugs & Pharmaceuticals Share Price

News

Welcure Drugs&Pharma reports Profit after tax of Rs -49.86 Crores, in the March 2026 quarter

Welcure Drugs & Pharmaceuticals informs about disclosure

Welcure Drugs&Pharma reports Profit after tax of 1.07 Crores, in the December 2025 quarter

Welcure Drugs & Pharmaceuticals informs about outcome of board meeting

Welcure Drugs&Pharma reports Profit after tax of 8.50 Crores, in the September 2025 quarter

Welcure Drugs & Pharmaceuticals informs about voting results

Welcure Drugs & Pharmaceuticals executes LoI with Telexcell Trade PTE

Welcure Drugs & Pharmaceuticals informs about newspaper publication

Welcure Drugs&Pharma - Quaterly Results

Welcure Drugs&Pharma - Quaterly Results

Welcure Drugs&Pharma reports Profit after tax of 23.30 Crores, in the June 2025 quarter

Welcure Drugs&Pharma - Quaterly Results

Welcure Drugs & Pharmaceuticals informs about updates

Welcure Drugs & Pharmaceuticals bags orders worth Rs 85.60 crore

Welcure Drugs & Pharmaceuticals informs about trading window closure

Welcure Drugs&Pharma reports Profit after tax of 2.54 Crores, in the March 2025 quarter

Welcure Drugs & Pharmaceutical informs about confirmation certificate

Welcure Drugs&Pharma - Quaterly Results

Welcure Drugs&Pharma reports Profit after tax of 41.50 Lakhs, in the December 2024 quarter

Welcure Drugs & Pharmaceuticals informs about board meeting outcome

Welcure Drugs & Pharmaceuticals Ltd Share Price Today

Welcure Drugs & Pharmaceuticals Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator